Please assess the completion status of the following clinical trial:

Trial Title: Intercostal Cryoneurolysis Following Traumatic Rib Fractures

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients of at least 18 years of age~* having 1-3 sustained rib fractures on either or both sides (if bilateral fractures, then total up to 6 fractures with up to 3 per side)~* regional anesthetic requested by the admitting service~* accepting of a cryoneurolysis procedure~Exclusion Criteria:~* chronic opioid use (daily use within the 2 weeks prior to surgery and duration of use \> 4 weeks~* pregnancy~* incarceration~* inability to communicate with the investigators~* morbid obesity (body mass index \> 40 kg/m2)~* possessing any contraindication specific to cryoneurolysis such as a localized infection at the treatment site, cryoglobulinemia, cold urticaria and Reynaud's Syndrome~* any patient unable to correctly perform incentive spirometry as this is an outcome measure~* any patient with any degree of decreased mental capacity as determined by the surgical service~* any reason an investigator believes study participation would not be in the best interest of the potential subject, including an anti-coagulated state

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cryoneurolysis (active) (Type: EXPERIMENTAL): The cryoneurolysis device will be triggered using 3 cycles of 2-minute gas activation (active or sham) separated by 1-minute defrost periods.
- Sham (Type: SHAM_COMPARATOR): For the sham probes, the nitrous oxide will be vented prior to reaching the probe shaft, resulting in a lack of perineural temperature change.

Based on this trial design, predict the completion outcome and termination type (if applicable).